Migraine. Providing educational information to patients about migraine disease in order to prevent or reduce the number of migraine headache attacks and its accompanying complications.. Migraine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffering from migraine headache Age range from 20 to 60 years old Having the ability to read and write Having an Android mobile phone . Ability to work with software Informed consent
Exclusion criteria
Exclusion criteria: Migraine patient whose number of attacks is less than twice a month Get a score higher than 20 for the level of depression and a score higher than 14 for the level of anxiety and a score higher than 25 for the level of stress according to the DASS-21 Botox therapeutic injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of migraine headache pain. Timepoint: Migraine headache pain intensity is measured at the beginning of the study and before the start of the intervention in both control and intervention groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after The intervention is measured in the intervention group. Method of measurement: Pain scoring tool.;Migraine headache duration. Timepoint: Migraine headache pain intensity is measured at the beginning of the study and before the start of the intervention in both control and intervention groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after the intervention is measured in the intervention group. Method of measurement: Patient report.;Number of migraine attacks. Timepoint: The number of migraine headache attacks is measured at the beginning of the study and before the start of the intervention in both groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after the intervention is measured in the intervention group. Method of measurement: Patient's report.;Complications associated with migraine such as eye and digestive complications. Timepoint: Complications are measured at the beginning of the study and before the start of the intervention in both groups and 7,14,21,28,35,42,49,56,63,70,77 and 84 days after the intervention in the intervention group. Method of measurement: Patient's report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Sabzevar University of Medical Sciences